Source document
Loading document…
KPIsSections20
| Revenue — GREEN | €131.7M | +14.0% YoY |
|---|---|---|
| Net income — GREEN | €19.9M | +20.3% YoY |
| Net margin — GREEN | 15.1% | |
| Operating margin — GREEN | 26.0% |
Income Statement
| Metric | Value | Flag |
|---|---|---|
| Revenue | €131.7M | GREEN |
| Operating Margin | 26.0% | GREEN |
| Net Margin | 15.1% | GREEN |
| Operating Income | €34.2M | GREEN |
| Net Income | €19.9M | GREEN |
| EBITDA | €38.1M | GREEN |
| Income Tax Expense | €10.3M | GREEN |
| Pre-tax Income | €30.2M | GREEN |
| EPS Diluted | €2090.00 | GREEN |
| Interest Expense | €1.1M | GREEN |
| Other Operating Expense/(Income) | €1.7M | GREEN |
| Interest and Investment Income | €965,000 | GREEN |
| Other Non Operating Income (Expenses) | €2.3M | GREEN |
| Earnings from Continuing Operations | €19.9M | GREEN |
Balance Sheet
| Metric | Value | Flag |
|---|---|---|
| Total Assets | €125.2M | GREEN |
| Current Assets | €72.9M | GREEN |
| Current Liabilities | €31.0M | GREEN |
| Total Liabilities | €54.0M | GREEN |
| Total Equity | €71.2M | GREEN |
| Noncontrolling Interest | -€112,000 | GREEN |
| Cash & Equivalents | €18.6M | GREEN |
| Trade Receivables | €24.8M | GREEN |
| Trade Payables | €19.9M | GREEN |
| Short Term Investments | €12.0M | GREEN |
| Inventory | €8.9M | GREEN |
| Other Current Assets | €7.8M | GREEN |
| Gross Property, Plant & Equipment | €24.1M | GREEN |
| Other Intangibles | €24.5M | GREEN |
| Other Long-Term Assets | €1.3M | GREEN |
| Other Current Liabilities | €4.5M | GREEN |
| Common Stock | €1.1M | GREEN |
| Treasury Stock | €5.9M | GREEN |
| Comprehensive Income and Other | €56.2M | GREEN |
Cash Flow
| Metric | Value | Flag |
|---|---|---|
| Capital Expenditures | €3.1M | GREEN |
| Investing Cash Flow | -€3.4M | GREEN |
| Depreciation & Amortization | €3.9M | GREEN |
| Financing Cash Flow | -€13.1M | GREEN |
| Asset Writedown & Restructuring Costs | €1.1M | GREEN |
| Change in Accounts Receivable | -€2.9M | GREEN |
| Change in Inventories | -€1.9M | GREEN |
| Change in Accounts Payable | €4.1M | GREEN |
| Change in Other Net Operating Assets | -€1.3M | GREEN |
| Sale of Property, Plant, and Equipment | €22,000 | GREEN |
| Common Dividends Paid | €9.6M | GREEN |
| Net Change in Cash | €3.1M | GREEN |
Sections in this filing
Business / Consolidation
Le società controllate sono le imprese in cui Pharmanutra ha il potere di determinare le scelte amministrative e gestionali; generalmente si tratta di esistenza del controllo quando il Gruppo detiene più della metà dei diritti di voto, o esercita un influenza dominante nelle scelte societarie ed operative delle stesse. Le società collegate sono quelle in cui Pharmanutra esercita un influenza notevole pur non avendone il controllo; generalmente essa si verifica quando si detiene tra il 20% ed il 49% dei diritti di voto. Le Società comprese nell'area di consolidamento, invariata rispetto all’esercizio precedente, sono le seguenti: